Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin D and Reduced Toll-Like Receptor 4 Positive Cell Count

Doses used in studies

IU/day: 1,000 (median 1,000, IQR 1,000–1,000) — 1 study

Time to effect

Median: 5 months · IQR 5 months–5 months · Range 5 months–5 months — Reported in 1 of 1 study

1 of 1 paper

Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy.
- 2016-07-01
- RCT
- Allergy and asthma proceedings 37(4)
- - Joanna Jerzynska
  - Wlodzimierz Stelmach
  - Joanna Balcerak
  - Katarzyna Woicka-Kolejwa
  - Blazej Rychlik
  - Andrzej Blauz
  - Marcin Wachulec
  - Piotr Stelmach
  - Pawel Majak
  - Iwona Stelmach
- PubMed: 27401319
- DOI: 10.2500/aap.2016.37.3958
5 Insights on
- Reduced Toll-Like Receptor 4 Positive Cell Count
- High evidence
- Clinical
higher reduction in the percentage of TLR-positive cell group compared with the SLIT-vitamin D group (Fig. 1).
Effect
Neutral
Effect size
Small
Significant
No
Dose
1000 IU/day